MetaCap

Black Diamond Therapeutics Inc. Company Profile

NASDAQ: BDTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.83+0.03 (+1.67%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

Black Diamond Therapeutics at a glance

Black Diamond Therapeutics Inc. (NASDAQ: BDTX) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2020. At a market capitalization of $103.4 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001701541, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

Company information

Legal name
Black Diamond Therapeutics Inc.
Ticker
NASDAQ: BDTX
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Headquarters
United States
IPO year
2020
Market cap
$103.42M
SEC CIK
0001701541

Companies similar to Black Diamond Therapeutics

BDTX peer companies
CompanyPrice% ChgMarket capCompare
ATRAAtara Biotherapeutics Inc.9.37-3.90%$94.05Mvs BDTX
LENZLENZ Therapeutics Inc.3.62-4.49%$113.74Mvs BDTX
ENGNenGene Therapeutics Inc.1.75-3.06%$116.94Mvs BDTX
CGTXCognition Therapeutics Inc.0.9366-0.36%$89.06Mvs BDTX
NMRANeumora Therapeutics Inc.0.4683-0.57%$87.99Mvs BDTX
CRDFCardiff Oncology Inc.1.09+1.87%$84.80Mvs BDTX
PTHSPelthos Therapeutics Inc.20.99-2.28%$80.36Mvs BDTX
GRMLGreenland Mines Ltd.5.83-8.62%$77.81Mvs BDTX

Related